CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 64279 | EN ISO 22367:2020 | Medical laboratories - Application of risk management to medical laboratories (ISO 22367:2020) | Atcelts |
| 27620 | LVS EN ISO 18113-5:2010 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 5: In vitro diagnostic instruments for self-testing (ISO 18113-5:2009) | Atcelts |
| 37589 | LVS EN ISO 18113-1:2012 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions and general requirements (ISO 18113-1:2009) | Atcelts |
| 5069 | EN 928:1995 | In vitro diagnostic systems - Guidance on the application of EN 29001 and EN 46001 and of EN 29002 and EN 46002 for in vitro diagnostic medical devices | Atcelts |
| 41033 | CEN/TS 16826-1:2015 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for snap frozen tissue - Part 1: Isolated RNA | Atcelts |
| 64590 | CEN/TS 16826-3:2018 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for snap frozen tissue - Part 3: Isolated DNA | Atcelts |
| 39727 | LVS EN ISO 23640:2013 | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents (ISO 23640:2011) | Atcelts |
| 37593 | EN ISO 18113-5:2011 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 5: In vitro diagnostic instruments for self-testing (ISO 18113-5:2009) | Atcelts |
| 65450 | CEN/TS 17390-1:2020 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood - Part 1: Isolated RNA | Atcelts |
| 5114 | LVS EN ISO 15189:2003 A | Medical laboratories - Particular requirements for quality and competence | Atcelts |
Displaying 111-120 of 282 results.